Folgen
Daniel F. Hayes
Daniel F. Hayes
professor internal medicine
Bestätigte E-Mail-Adresse bei umich.edu
Titel
Zitiert von
Zitiert von
Jahr
College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
AC Wolff, ME Hammond, JN Schwartz, KL Hagerty, DC Allred, RJ Cote, ...
J clin oncol 25 (1), 118-145, 2007
59052007
College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
ME Hammond, DF Hayes, M Dowsett, DC Allred, KL Hagerty, S Badve, ...
J Clin Oncol 28 (16), 2784-2795, 2010
53022010
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice …
AC Wolff, MEH Hammond, DG Hicks, M Dowsett, LM McShane, ...
Archives of Pathology and Laboratory Medicine 138 (2), 241-256, 2014
52932014
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli, GT Budd, MJ Ellis, A Stopeck, J Matera, MC Miller, ...
New England Journal of Medicine 351 (8), 781-791, 2004
52672004
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
C Ginestier, MH Hur, E Charafe-Jauffret, F Monville, J Dutcher, M Brown, ...
Cell stem cell 1 (5), 555-567, 2007
48332007
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
42752013
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in …
MEH Hammond, DF Hayes, M Dowsett, DC Allred, KL Hagerty, S Badve, ...
Archives of pathology & laboratory medicine 134 (7), e48-e72, 2010
39032010
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
AC Wolff, MEH Hammond, JN Schwartz, KL Hagerty, DC Allred, RJ Cote, ...
Archives of pathology & laboratory medicine 131 (1), 18-43, 2007
38122007
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
L Harris, H Fritsche, R Mennel, L Norton, P Ravdin, S Taube, ...
Journal of clinical oncology 25 (33), 5287-5312, 2007
32982007
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
22162015
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 379 (9814), 432-444, 2012
21892012
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group
M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ...
Journal of the National cancer Institute 103 (22), 1656-1664, 2011
20132011
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ...
New England Journal of Medicine 379 (2), 111-121, 2018
20032018
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer, Q Cao, S Varambally, R Shen, I Ota, SA Tomlins, D Ghosh, ...
Proceedings of the national academy of sciences 100 (20), 11606-11611, 2003
19802003
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
GY Locker, S Hamilton, J Harris, JM Jessup, N Kemeny, JS Macdonald, ...
Journal of clinical oncology 24 (33), 5313-5327, 2006
19512006
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women …
P McGale, C Taylor, C Correa, D Cutter, F Duane, M Ewertz, R Gray, ...
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2014
1846*2014
Revision of the American Joint Committee on Cancer staging system for breast cancer
SE Singletary, C Allred, P Ashley, LW Bassett, D Berry, KI Bland, ...
Journal of clinical oncology 20 (17), 3628-3636, 2002
17862002
Prognostic factors in breast cancer: College of American Pathologists consensus statement 1999
PL Fitzgibbons, DL Page, D Weaver, AD Thor, DC Allred, GM Clark, ...
Archives of pathology & laboratory medicine 124 (7), 966-978, 2000
17852000
Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast …
IC Henderson, DA Berry, GD Demetri, CT Cirrincione, LJ Goldstein, ...
Journal of clinical oncology 21 (6), 976-983, 2003
17242003
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a …
KS Albain, WE Barlow, S Shak, GN Hortobagyi, RB Livingston, IT Yeh, ...
The lancet oncology 11 (1), 55-65, 2010
15892010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20